Overcoming Barriers to Optimal Diagnosis and Treatment of Invasive Fungal Infections: Practical Guidance for the Hospital-Based Healthcare Provider
November 5, 2018
September 3, 2019
Time to Complete Activity
Activity Description and Educational Objectives
In this activity, an infectious diseases specialist and a clinical pharmacist provide practical guidance for diagnosing and treating invasive fungal infections in the hospital setting.
Upon completion of this activity, participants will be able to:
- PROMPTLY EVALUATE high-risk patients with signs or symptoms that are suggestive of systemic fungal infection to mitigate the impact of delayed recognition and initiation of empiric antifungal therapy
- IDENTIFY the benefits and limitations of new therapies for invasive fungal infections
- APPLY the most recent evidence-based guidelines and expert recommendations in order to optimize the efficacy, tolerability, and cost-effectiveness of antifungal therapy in individual patients
- RECOGNIZE the role of the multidisciplinary team in monitoring and directing the appropriate use of antifungal agents
This activity has been designed to meet the educational needs of hospitalists, hospital-based pharmacists, and other clinicians involved in the management of patients with invasive fungal infections.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME/MOC/CPE credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/MOC/CPE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Faculty & Disclosure/Conflict of Interest Policy
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/MOC/CPE activity during the past 12 months.
Course Director and Moderator
Thomas F. Patterson, MD, FACP, FIDSA
Vice-Chair for Faculty Development
Chief, Division of Infectious Diseases
Professor of Medicine
Director, San Antonio Center for Medical Mycology
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
Thomas F. Patterson, MD, FACP, FIDSA, has a financial interest/relationship or affiliation in the form of:
Consultant for Basilea Pharmaceutica Ltd.; Gilead; Pfizer Inc.; and Toyama.
Grant/Research Support from Cidara Therapeutics, Inc. and F2G Limited.
Advisory Board for Astellas Pharma US, Inc; Gilead; Merck & Co., Inc.; and Scynexis, Inc.
Other Financial or Material Support from Merck & Co., Inc. in the form of a Data Review Committee.
Thomas F. Patterson, MD, FACP, FIDSA, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.
James S. Lewis II, PharmD, FIDSA
Infectious Diseases Clinical Pharmacy Supervisor
Oregon Heatlh & Science University
James S. Lewis II, PharmD, FIDSA, has a financial interest/relationship or affiliation in the form of:
Consultant for Merck & Co., Inc.
Advisory Board for Merck & Co., Inc.
James S. Lewis II, PharmD, FIDSA, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.
Matthew A. Goodman, MD
Matthew A. Goodman, MD, has no financial interests/relationships or affiliations in relation to this activity.
Nancy Nesser, JD, PharmD
Nancy Nesser, JD, PharmD, has no financial interests/relationships or affiliations in relation to this activity.
Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education
Kathryn B. Charalambous, PhD, has no financial interests/relationships or affiliations in relation to this activity.
The information provided at this CME/MOC/CPE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.
Providership, Credit & Support
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participation information will be shared with ABIM through the ACCME's Program Reporting and Activity System (PARS). Individual or aggregated participant data may be shared with the funder of the activity.
The Medical Learning Institute, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of this knowledge-based activity provides for 0.5 contact hours (0.05 CEUs) of continuing pharmacy education credit. The Universal Activity Number for this activity is 0468-9999-18-011-H01-P.
This CME/MOC/CPE activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from Astellas.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer's product labeling.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.
About This CME/MOC/CPE Activity
PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity's topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.
Copyright © 2000-2018, PeerView
Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care
professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing
education for the broad spectrum of health care professionals. This site features a searchable database of accredited
Power-Pak C.E.® courses on important topics for today's health care professionals.
PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants
may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates
for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new
courses available on the site.